The 29th Annual Prostate Cancer Foundation Scientific Retreat Report
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The 29th Annual Prostate Cancer Foundation Scientific Retreat Report
Authors
Keywords
-
Journal
PROSTATE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-11-02
DOI
10.1002/pros.24640
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy
- (2023) Anil P. Bidkar et al. CLINICAL CANCER RESEARCH
- Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
- (2023) Jamie M. Sperger et al. CLINICAL CANCER RESEARCH
- Predicting Prostate Cancer Molecular Subtype with Deep Learning on Histopathologic Images
- (2023) Eric Erak et al. MODERN PATHOLOGY
- Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
- (2023) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of self-identified race and genetic ancestry with the immunogenomic landscape of primary prostate cancer
- (2023) Thiago Vidotto et al. JCI Insight
- Landscape of prostate-specific membrane antigen heterogeneity and regulation in AR-positive and AR-negative metastatic prostate cancer
- (2023) Martin K. Bakht et al. Nature Cancer
- Multi-level functional genomics reveals molecular and cellular oncogenicity of patient-based 3′ untranslated region mutations
- (2023) Samantha L. Schuster et al. Cell Reports
- A Bispecific γδ T-cell Engager Targeting EGFR Activates a Potent Vγ9Vδ2 T cell–Mediated Immune Response against EGFR-Expressing Tumors
- (2023) Lisa A. King et al. Cancer Immunology Research
- The Akt/mTOR and MNK/eIF4E pathways rewire the prostate cancer translatome to secrete HGF, SPP1 and BGN and recruit suppressive myeloid cells
- (2023) Daniela Brina et al. Nature Cancer
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
- (2022) Kathryn M. Tully et al. CLINICAL CANCER RESEARCH
- Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy
- (2022) Qing Cheng et al. EUROPEAN UROLOGY
- Phase 1 study of JNJ-69086420, an actinium-225-labeled antibody targeting human kallikrein-2, for advanced prostate cancer.
- (2022) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor activity in T cells limits checkpoint blockade efficacy
- (2022) Xiangnan Guan et al. NATURE
- Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma
- (2022) Saketh S. Dinavahi et al. Cancer Immunology Research
- Phase 1a/1b study of FOR46, an antibody drug conjugate (ADC), targeting CD46 in metastatic castration-resistant prostate cancer (mCRPC).
- (2022) Rahul Raj Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Novel Hormonal Therapy Followed by Prostatectomy versus Up-Front Prostatectomy for High-Risk Prostate Cancer: A Comparative Analysis
- (2022) Praful Ravi et al. JOURNAL OF UROLOGY
- Biological Aspects of Cancer Health Disparities
- (2021) Jennifer A. Freedman et al. Annual Review of Medicine
- Differential alternative RNA splicing and transcription events between tumors from African American and white patients in The Cancer Genome Atlas
- (2021) Muthana Al Abo et al. GENOMICS
- Pretherapeutic first-in-human targeting trial of anti-hK2 antibody h11B6: A potential molecular vector for alpha-particle radioimmunotherapy.
- (2021) Michael J. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes Post Neoadjuvant Intense Hormone Therapy and Surgery for Patients with High-Risk Localized Prostate Cancer: Results of a Pooled Analysis of Contemporary Clinical Trials
- (2021) Rana R. McKay et al. JOURNAL OF UROLOGY
- Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer
- (2021) Rebeca Lozano et al. EUROPEAN JOURNAL OF CANCER
- Impact of Pathogenic Germline DNA Damage Repair alterations on Response to Intense Neoadjuvant Androgen Deprivation Therapy in High-risk Localized Prostate Cancer
- (2021) Jacob E. Berchuck et al. EUROPEAN UROLOGY
- The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors
- (2021) Benoit Rousseau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancer
- (2021) W. Nathaniel Brennen et al. JCI Insight
- Prospective Evaluation of Clinical Outcomes Using a Multiplex Liquid Biopsy Targeting Diverse Resistance Mechanisms in Metastatic Prostate Cancer
- (2021) Jamie M. Sperger et al. JOURNAL OF CLINICAL ONCOLOGY
- Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
- (2021) Christopher Sweeney et al. LANCET
- Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade
- (2021) Ravi B. Patel et al. Science Translational Medicine
- Multiplexed functional genomic analysis of 5’ untranslated region mutations across the spectrum of prostate cancer
- (2021) Yiting Lim et al. Nature Communications
- Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer
- (2021) Nicholas J. Brady et al. Nature Communications
- Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers
- (2021) Ninghui Mao et al. Nature Communications
- Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation
- (2021) Alvaro Quintanal-Villalonga et al. Cancer Discovery
- Reshaping of the androgen-driven chromatin landscape in normal prostate cells by early cancer drivers and effect on therapeutic sensitivity
- (2021) Ivana Grbesa et al. Cell Reports
- Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancer
- (2021) Alok K. Tewari et al. Cell Reports
- Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
- (2021) Alvaro Quintanal-Villalonga et al. CANCER RESEARCH
- Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses
- (2021) Joseph Sia et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry
- (2020) Jiao Yuan et al. PLoS Genetics
- Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress
- (2020) Michael D. Nyquist et al. Cell Reports
- Human γδ TCR Repertoires in Health and Disease
- (2020) Alina Suzann Fichtner et al. Cells
- Cancer immunotherapy with γδ T cells: many paths ahead of us
- (2020) Dieter Kabelitz et al. Cellular & Molecular Immunology
- Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
- (2020) Mesude Bicak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET
- (2020) Sinan Wang et al. CLINICAL CANCER RESEARCH
- Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
- (2020) Sara A. Hurvitz et al. Nature Communications
- Evaluation of Intense Androgen Deprivation Before Prostatectomy: A Randomized Phase II Trial of Enzalutamide and Leuprolide With or Without Abiraterone
- (2019) Rana R. McKay et al. JOURNAL OF CLINICAL ONCOLOGY
- Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities
- (2019) Timothy J. Robinson et al. CLINICAL CANCER RESEARCH
- The Landscape of Circular RNA in Cancer
- (2019) Josh N. Vo et al. CELL
- Widespread and Functional RNA Circularization in Localized Prostate Cancer
- (2019) Sujun Chen et al. CELL
- CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis
- (2019) Michael A. Augello et al. CANCER CELL
- The androgen receptor regulates a druggable translational regulon in advanced prostate cancer
- (2019) Yuzhen Liu et al. Science Translational Medicine
- Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small Cell Lung Cancer: Results From the Phase II TRINITY Study
- (2019) Daniel Morgensztern et al. CLINICAL CANCER RESEARCH
- The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
- (2019) Todd C. Knepper et al. CLINICAL CANCER RESEARCH
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
- (2019) Aurelien Marabelle et al. JOURNAL OF CLINICAL ONCOLOGY
- Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
- (2018) Michael R. McDevitt et al. Nature Communications
- Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy
- (2017) Jeffrey J. Tosoian et al. EUROPEAN UROLOGY
- Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model
- (2017) Ying-Chun Shen et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma
- (2017) Gabriel J. Starrett et al. mBio
- Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer
- (2017) Bi-Dar Wang et al. Nature Communications
- Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations
- (2017) Franklin W. Huang et al. Cancer Discovery
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
- (2017) Marie Tosolini et al. OncoImmunology
- Functional characterization of somatic mutations in cancer using network-based inference of protein activity
- (2016) Mariano J Alvarez et al. NATURE GENETICS
- CIS is a potent checkpoint in NK cell–mediated tumor immunity
- (2016) Rebecca B Delconte et al. NATURE IMMUNOLOGY
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline neutrophil–lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use
- (2014) D. Lorente et al. ANNALS OF ONCOLOGY
- Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men
- (2014) F. Khani et al. CLINICAL CANCER RESEARCH
- Protective Immunosurveillance and Therapeutic Antitumor Activity of γδ T Cells Demonstrated in a Mouse Model of Prostate Cancer
- (2014) Zhiyong Liu et al. JOURNAL OF IMMUNOLOGY
- Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
- (2014) Diletta Di Mitri et al. NATURE
- Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy
- (2014) J. P. Weichert et al. Science Translational Medicine
- Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
- (2014) Priyanka Sathe et al. Nature Communications
- Genes Associated with Prostate Cancer Are Differentially Expressed in African American and European American Men
- (2013) I. J. Powell et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
- (2008) T. A. Wallace et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now